HOPE Center Applauds Student Presentations at International Conference

June 13, 2022
Students presenting at ISPOR

HOPE Center congratulates five doctoral students (Almatruk, Bin Awad, Choi, Obeng-Kusi, Whaley) and one recent graduate (Dhatt) on their outstanding presentations at the International Society of Pharmacoeconomic & Outcomes Research (ISPOR) annual meeting in Washington, DC. Dhatt's abstract was further recognized as a "top 5% finalist" of more than 1,600 accepted abstracts for the ISPOR 2022 Research Presentation Awards. We are proud of their scientific contributions, representing the HOPE Center and the Health & Pharmaceutical Outcomes graduate program, and all their supportive faculty mentors. Click the links below to learn more about these important studies!

  1. Factors Associated with Pneumococcal Vaccine Uptake Among Vulnerable Populations in the Primary Care Setting
  • Whaley S1, Axon D2
    1University of Arizona, Troy, MI, USA, 2University of Arizona, Tucson, AZ, USA
  1. Cost-Effectiveness of the Chest Pain Choice Decision Aid Versus Usual Care Among Low-Risk Chest Pain Patients Presenting to the Emergency Department
  • Dhatt H1, Hurwitz JT2, Axon D2, Warholak T2, Slack M2, Grizzle AJ2
    1University of Arizona (time of research) | Janssen (current), Scottsdale, AZ, USA, 2University of Arizona, Tucson, AZ, USA
  1. Factors Associated with Good Mental Health Among US Adults with Arthritis
  • Bin Awad N, Axon D
    University of Arizona, Tucson, AZ, USA
  1. Variables Associated with Frequent Exercise Among us Adults with Asthma
  • Almatruk Z, Axon D
    University of Arizona, Tucson, AZ, USA
  1. Comorbidities and Perceived Health Status in Persons with Cancer: A Retrospective Analysis of the Medical Expenditure Panel Survey (MEPS).
  • Obeng-Kusi M, Axon D
    University of Arizona, Tucson, AZ, USA
  1. Association between Patient-Physician Communication and Perceived Mental Health Status Among United States Adults with Cancer
  • Choi B, Axon D
    University of Arizona, Tucson, AZ, USA
  1. Value-Based Pricing of an Ebola Vaccine in Resource-Constrained Countries Based on Cost-Effectiveness Analysis